News Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
22.39 ^CNY	+2.05%		+2.99%	-2.10%

May. 17	Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	CI
Apr. 19	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	May. 16	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
YHLO Biotech Secures US FDA Clearance for Two In-Vitro Diagnostics Products	Dec. 13	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index	23-09-18	CI
YHLO Biotech Registers Reagent For Detecting Heart Failure	23-09-14	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2023.	23-05-16	CI
YHLO Biotech Unit Gets Certification for Two Medical Devices	23-05-10	MT
YHLO Biotech Unit Registers New Medical Device	23-05-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
YHLO Biotech Gets Registration Certificate for Automatic Biochemical Analyzer	23-04-05	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
YHLO Biotech Gets Registration Certificate for Anti-Desmoglein 3 Antibody Detection Kit	23-02-03	MT
YHLO Biotech's COVID-19 Antigen Kit Added to WHO's Emergency Use List	22-11-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors.	22-10-24	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-20	CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange A Share Index	22-05-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Summary

Filters